Cerus Corp (CERS) Posts Q2 EPS Loss of $0.13
Tweet
Share
E-mailGet Alerts CERS Hot Sheet
Price: $2.82 +4.06%
Financial Fact:
Product revenue: 10.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product revenue: 10.18M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cerus Corp (NASDAQ: CERS) reported Q2 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $6.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
